Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 839713-36-9
2. Apd125
3. Apd-125
4. 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
5. 1-[3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
6. 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
7. 4za73qew2p
8. Chembl598172
9. 1-(3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl)-3-(2,4-difluorophenyl)urea
10. N-[3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl]-n'-(2,4-difluorophenyl)-urea
11. Nelotanserin [usan:inn]
12. Unii-4za73qew2p
13. Apd125(nelotanserin)
14. Nelotanserin (usan/inn)
15. Nelotanserin [inn]
16. Nelotanserin [usan]
17. Schembl2345325
18. Apd 125
19. Dtxsid40232868
20. Chebi:177438
21. Bcp24992
22. Ex-a3147
23. Bdbm50324541
24. Mfcd16619341
25. Zinc38239930
26. Cs-5984
27. Db12555
28. Sb19023
29. As-30117
30. Hy-10559
31. D09645
32. 713b369
33. Q6990276
34. 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea
35. 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea
36. 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-diluorophenyl)urea
37. 1-(3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl)-3-(2,4- Difluorophenyl)urea
38. Urea, N-(3-(4-bromo-1-methyl-1h-pyrazol-5-yl)-4-methoxyphenyl)-n'-(2,4-difluorophenyl)-
| Molecular Weight | 437.2 g/mol |
|---|---|
| Molecular Formula | C18H15BrF2N4O2 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 436.03464 g/mol |
| Monoisotopic Mass | 436.03464 g/mol |
| Topological Polar Surface Area | 68.2 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 518 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Nelotanserin potently and selectively targets the 5-HT2A serotonin receptor, blocking a stimulatory pathway of the central nervous system. This mechanism is not expected to have the side effects of the GABA-A treatments.
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
64
PharmaCompass offers a list of Nelotanserin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nelotanserin manufacturer or Nelotanserin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nelotanserin manufacturer or Nelotanserin supplier.
PharmaCompass also assists you with knowing the Nelotanserin API Price utilized in the formulation of products. Nelotanserin API Price is not always fixed or binding as the Nelotanserin Price is obtained through a variety of data sources. The Nelotanserin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nelotanserin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nelotanserin, including repackagers and relabelers. The FDA regulates Nelotanserin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nelotanserin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nelotanserin supplier is an individual or a company that provides Nelotanserin active pharmaceutical ingredient (API) or Nelotanserin finished formulations upon request. The Nelotanserin suppliers may include Nelotanserin API manufacturers, exporters, distributors and traders.
Nelotanserin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nelotanserin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nelotanserin GMP manufacturer or Nelotanserin GMP API supplier for your needs.
A Nelotanserin CoA (Certificate of Analysis) is a formal document that attests to Nelotanserin's compliance with Nelotanserin specifications and serves as a tool for batch-level quality control.
Nelotanserin CoA mostly includes findings from lab analyses of a specific batch. For each Nelotanserin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nelotanserin may be tested according to a variety of international standards, such as European Pharmacopoeia (Nelotanserin EP), Nelotanserin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nelotanserin USP).
